J7352 HCPCS Level II code: Afamelanotide implant, 1 mg
J7352 is the HCPCS code for “Afamelanotide implant, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7352Afamelanotide implant, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J7352 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2021
Where J7352 sits
- 1J codesDrugs administered other than orally
- 2Active code J7352Afamelanotide implant, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7352 mean?
J7352 is the HCPCS code for “Afamelanotide implant, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7352?
CMS lists J7352’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7352
All J codesJ7335Capsaicin 8% patch, per 10 square centimetersJ7336Capsaicin 8% patch, per square centimeterJ7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 mlJ7342Instillation, ciprofloxacin otic suspension, 6 mgJ7345Aminolevulinic acid hcl for topical administration, 10% gel, 10 mgJ7351Injection, bimatoprost, intracameral implant, 1 microgramJ7353Anacaulase-bcdb, 8.8% gel, 1 gramJ7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)J7355Injection, travoprost, intracameral implant, 1 microgramJ7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mgJ7401Mometasone furoate sinus implant, 10 microgramsJ7402Mometasone furoate sinus implant, (sinuva), 10 micrograms